Abstract Purpose of Review Over the last ten years, the treatment of psychosis has seen a
near explosion of creative development in both novel agents and new delivery modalities …

Tourette syndrome (TS) is a chronic neurodevelopmental disorder characterized by tics:
repetitive, involuntary movements and vocalizations. These symptoms can have a significant …

OBJECTIVE: BETA was designed to evaluate the overall effectiveness of aripiprazole in
patients with schizophrenia or schizoaffective disorder treated in a general psychiatry …

Objective These cases illustrate that a new neuroleptic, aripiprazole, may be an effective
treatment for the motor and vocal tics of Tourette Syndrome (TS), even in younger people …

Aripiprazole is a new atypical antipsychotic drug with a partial agonist activity at dopamine 2
and serotonin 1A receptors. The metabolism of aripiprazole involves both cytochrome P450 …

Background Aripiprazole lauroxil is an extended-release prodrug of aripiprazole for
intramuscular injection, approved for schizophrenia treatment. We developed a population …

Aripiprazole has been approved by regulatory agencies for the treatment of schizophrenia
and bipolar I disorder. Although it is a dopamine partial agonist, it also has substantial …

The metabolic syndrome (MetS) is a well described cluster of interrelated risk factors for
developing cardiovascular disease and type 2 diabetes. The key components of MetS are …

New generation antipsychotic (NGA) drugs introduced to the US market after clozapine
(aripiprazole, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) are …

Aripiprazole has been used effectively to treat schizophrenia in the clinic; however, its
mechanisms of action are not clear. This study examined how short-and long-term …